Venture-Backed BioAmber Completes IPO on NYSE

BioAmber Inc., a company focused on converting renewable feedstocks into chemicals including succinic acid, has now closed its initial public offering at US$80 million. The company's units are listed on the New York Stock Exchange under the symbol "BIOA.U".. BioAmber, which has offices in Montréal and Minneapolis, Minnesota, is backed by U.S.-based venture capital firms and other investors, including include Clifton Group, LANXESS, Mitsui, Naxos Capital and Sofinnova Partners.

DealsCanadaNorth AmericaBriefs